SCHEMBL5670293

SCHEMBL5670293

N=C(N)N(C(=O)c1ccc2ccccc2c1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 7/20 0.59
F2 P00734 3/20 0.53
PLG P00747 2/20 0.53
KLKB1 P03952 2/20 0.53
KLK1 P06870 2/20 0.53
PRSS1 P07477 2/20 0.53
ESR1 P03372 1/20 0.50
ESR2 Q92731 1/20 0.50
PLAT P00750 1/20 0.48
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
F10 P00742 1/20 0.43
F7 P08709 1/20 0.43
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
EGFR P00533 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5670526 0.90 PLAU (0.56) PLAUF2PLGKLKB1KLK1
SCHEMBL5672471 0.83 PLAU (0.48) PLAUF2PLGKLKB1KLK1
SCHEMBL7075852 0.82 TDP1 (0.49) PLAUF2PRSS1CES1F10
SCHEMBL5431379 0.81 PLAU (0.59) PLAUF2PLGKLKB1KLK1
SCHEMBL10588465 0.81 ESR1 (0.49) PLAUF2PLGKLKB1KLK1
SCHEMBL5430181 0.78 PLAU (0.56) PLAUF2PLGKLKB1KLK1
SCHEMBL11848661 0.78 ESR1 (0.59) PLAUF2PLGKLKB1KLK1
SCHEMBL27443700 0.77 ESR1 (0.78) PLAUF2PLGKLKB1KLK1
SCHEMBL5051900 0.76 KDM4E (0.58) PLAUESR1ESR2CES2CES1
SCHEMBL8010469 0.75 ESR1 (0.52) PLAUESR1ESR2CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646371-A2 ANTIVIRAL COMPOUNDS AND METHODS Biotron Limited (AU) 2006-04-19 EP claimed
WO-2004112687-A2 ANTIVIRAL ACYLGUANIDINE COMPOUNDS AND METHODS BIOTRON LIMITED (AU) 2004-12-29 WO claimed
EP-2617709-A1 Guanidine derivatives as antiviral agents Biotron Limited (AU) 2013-07-24 EP disclosed
EP-1646371-A2 ANTIVIRAL COMPOUNDS AND METHODS Biotron Limited (AU) 2006-04-19 EP disclosed
WO-2004112687-A2 ANTIVIRAL ACYLGUANIDINE COMPOUNDS AND METHODS BIOTRON LIMITED (AU) 2004-12-29 WO disclosed